Intraperitoneal chemotherapy following refractory intravenous route in advanced ovarian cancer.

Intraperitoneal chemotherapy following refractory intravenous route in advanced ovarian cancer.

Platinum based adjuvant chemotherapy is generally recommended for ovarian cancer to improve the survival rate. Intravenous route is commonly used, easily administered and less associated complications. However, intraperitoneal route is gaining its popularity as a single procedure or adjunctive to th...

Full description

Bibliographic Details
Main Authors: Shafiee MN, Omar MH, Suraya A, Hatta M
Format: Article
Language:English
Published: Department of Surgery, UKM Medical Centre 2013
Online Access:http://journalarticle.ukm.my/6672/
http://journalarticle.ukm.my/6672/
http://journalarticle.ukm.my/6672/1/09-MS1079_%2828-31%29.pdf
id ukm-6672
recordtype eprints
spelling ukm-66722016-12-14T06:41:52Z http://journalarticle.ukm.my/6672/ Intraperitoneal chemotherapy following refractory intravenous route in advanced ovarian cancer. Shafiee MN, Omar MH, Suraya A, Hatta M, Platinum based adjuvant chemotherapy is generally recommended for ovarian cancer to improve the survival rate. Intravenous route is commonly used, easily administered and less associated complications. However, intraperitoneal route is gaining its popularity as a single procedure or adjunctive to the intravenous route. Numerous questions on its eligibility and safety are still perplexed. A case review on a patient with non optimal debulking surgery of advanced ovarian cancer was studied. Intravenous platinum based chemotherapy combined with paclitaxel failed to bring her to clinical remission. Second line chemotherapy, gemcitabin rendered her to poor response with unresolved debilitating ascites needing recurrent drainage. Surprisingly, a trial of intraperitoneal chemotherapy with cisplatin revealed a great response with a complete clinical remission. Department of Surgery, UKM Medical Centre 2013-02 Article PeerReviewed application/pdf en http://journalarticle.ukm.my/6672/1/09-MS1079_%2828-31%29.pdf Shafiee MN, and Omar MH, and Suraya A, and Hatta M, (2013) Intraperitoneal chemotherapy following refractory intravenous route in advanced ovarian cancer. Journal of Surgical Academia, 3 (1). pp. 28-31. ISSN 2231-7481 http://jsurgacad.com/
repository_type Digital Repository
institution_category Local University
institution Universiti Kebangasaan Malaysia
building UKM Institutional Repository
collection Online Access
language English
description Platinum based adjuvant chemotherapy is generally recommended for ovarian cancer to improve the survival rate. Intravenous route is commonly used, easily administered and less associated complications. However, intraperitoneal route is gaining its popularity as a single procedure or adjunctive to the intravenous route. Numerous questions on its eligibility and safety are still perplexed. A case review on a patient with non optimal debulking surgery of advanced ovarian cancer was studied. Intravenous platinum based chemotherapy combined with paclitaxel failed to bring her to clinical remission. Second line chemotherapy, gemcitabin rendered her to poor response with unresolved debilitating ascites needing recurrent drainage. Surprisingly, a trial of intraperitoneal chemotherapy with cisplatin revealed a great response with a complete clinical remission.
format Article
author Shafiee MN,
Omar MH,
Suraya A,
Hatta M,
spellingShingle Shafiee MN,
Omar MH,
Suraya A,
Hatta M,
Intraperitoneal chemotherapy following refractory intravenous route in advanced ovarian cancer.
author_facet Shafiee MN,
Omar MH,
Suraya A,
Hatta M,
author_sort Shafiee MN,
title Intraperitoneal chemotherapy following refractory intravenous route in advanced ovarian cancer.
title_short Intraperitoneal chemotherapy following refractory intravenous route in advanced ovarian cancer.
title_full Intraperitoneal chemotherapy following refractory intravenous route in advanced ovarian cancer.
title_fullStr Intraperitoneal chemotherapy following refractory intravenous route in advanced ovarian cancer.
title_full_unstemmed Intraperitoneal chemotherapy following refractory intravenous route in advanced ovarian cancer.
title_sort intraperitoneal chemotherapy following refractory intravenous route in advanced ovarian cancer.
publisher Department of Surgery, UKM Medical Centre
publishDate 2013
url http://journalarticle.ukm.my/6672/
http://journalarticle.ukm.my/6672/
http://journalarticle.ukm.my/6672/1/09-MS1079_%2828-31%29.pdf
first_indexed 2023-09-18T19:47:33Z
last_indexed 2023-09-18T19:47:33Z
_version_ 1777406002006589440

Similar Items